Dechra Pharmaceuticals plc

Headquarters: Northwich, United Kingdom

Founded: 1997

Employees: 1,699

CEO: Mr. Ian D. Page


Market Cap

£4.39 Billion

GBP as of Jan. 1, 2024

US$5.59 Billion

Market Cap History

Dechra Pharmaceuticals plc market capitalization over time

Evolution of Dechra Pharmaceuticals plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Dechra Pharmaceuticals plc

Detailed Description

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Dechra Pharmaceuticals plc has the following listings and related stock indices.

Stock: LSE: DPH wb_incandescent

Stock: FSX: 1PK wb_incandescent

Key People

Tony Rice, (Chairman) Ian Page, (CEO)


Revenue: £608.0 million (2021)

Operating income: £162.2 million (2021)

Net income: £55.5 million (2021)



24 Cheshire Avenue

Cheshire Business Park Lostock Gralam

Northwich, CW9 7UA

United Kingdom

Phone: 44 1606 814730

Fax: 44 1606 814731